NEW YORK, April 30, 2012 /PRNewswire/ -- Tripp Levy PLLC, a
leading national securities law firm, is investigating the Senior
Management and the Board of Directors of Gen-Probe Inc. (NASDAQ:
GPRO) for possible breaches of fiduciary duty and other
violations of state law. On April 30,
2012, Hologic, Inc. (NASDAQ: HOLX) announced that it has
entered into a definitive merger agreement whereby Hologic will
acquire all the outstanding shares of Gen-Probe for $82.75 per share in cash.
The investigation concerns, among other things, whether the
consideration to be paid to Gen-Probe shareholders is unfair,
inadequate, and substantially below the fair or inherent value of
Gen-Probe, and whether the senior management of Gen-Probe are
putting their own self-interests ahead of that of the Company's
shareholders. Indeed, analysts project Gen-Probe's true going
forward value is in excess of the merger consideration.
If you own common stock in Gen-Probe and wish to obtain
additional information, please contact us at:
Tripp Levy PLLC
Toll free: 877-772-3975
Email: contact@tripplevy.com
www.tripplevy.com
SOURCE Tripp Levy PLLC